In 2019, the state passed a bill to create a trust fund for UAMS for it to achieve national cancer institute designation. The state contributed $170 million and UAMS raised the remaining $30 million through 8,700 philanthropic gifts.
UAMS aims to finalize and submit its application for designation within the next year. It is focusing on increasing clinical trials — intending to go from 150 to 250 by 2025 — and community outreach, both key factors in designation consideration.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
